BitMEX co-founder and Bitcoin billionaire Arthur Hayes has joined the board of a stem cell company and become a major shareholder after being pardoned by U.S. President Trump in March this year, clearing his conviction record for violating the Bank Secrecy Act.
Hayes stated that he has been receiving treatment at the company's clinics in Mexico and Bangkok for over a year. He had developed BitMEX into one of the largest derivatives trading platforms in the world but later faced an investigation due to regulatory issues.
"I want to live as long and as healthily as possible," Hayes said, noting that more and more countries are relaxing regulations on stem cell applications. The company is currently undergoing a name change, which has not yet been disclosed.
In March, Trump pardoned four former BitMEX executives, including Hayes, Benjamin Delo, Gregory Dwyer, and Samuel Reed, who pleaded guilty due to the exchange's weak anti-money laundering measures and violations of the Bank Secrecy Act.
Hayes' investment in the longevity sector comes as crypto industry giants are increasingly channeling their wealth into this field.
In 2021, Vitalik Buterin donated $25 million worth of Shiba Inu (SHIB) to the Future of Life Institute and over $350,000 to the SENS Research Foundation to "redefine aging."
He emphasized that extending lifespan is a worthy endeavor and views it as a way to end the generational losses caused by aging. Buterin stated that even if the aging process becomes reversible and a common phenomenon in people's lives, humans could potentially live to 150, 200 years, or even longer.
Former Coinbase executive Balaji Srinivasan also co-founded the genetic testing startup Counsyl, focusing on affordable reproductive health and disease screening genetic tests. Meanwhile, the genetic startup NewLimit, co-founded by Coinbase CEO Brian Armstrong, raised $130 million this year.
Cointelegraph reached out to Maelstrom for comment, but no response had been received by the time of publication.
Hayes remains active at the forefront of crypto finance. His family office, Maelstrom, has supported digital asset custody companies and publicly traded companies holding tokens on their balance sheets.
Last year, Hayes' Maelstrom fund launched a Bitcoin developer grant program, providing annual funding of $50,000 to $150,000. Individual developers can receive up to $250,000 to support open-source projects that enhance Bitcoin's scalability, resilience, privacy, and censorship resistance.
Related: Bitcoin (BTC) drops nearly $112,000 as investors await Powell's speech
Original article: “Arthur Hayes shifts to the longevity sector, investing in a stem cell company after Trump’s pardon”
免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。
